NAPOLITANO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 7.790
AS - Asia 6.399
EU - Europa 4.828
SA - Sud America 898
AF - Africa 201
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 20.139
Nazione #
US - Stati Uniti d'America 7.648
CN - Cina 3.246
SG - Singapore 1.352
IE - Irlanda 1.113
HK - Hong Kong 708
UA - Ucraina 668
BR - Brasile 663
DE - Germania 527
RU - Federazione Russa 508
VN - Vietnam 476
IT - Italia 459
FI - Finlandia 386
FR - Francia 377
SE - Svezia 351
GB - Regno Unito 246
IN - India 126
AR - Argentina 85
ZA - Sudafrica 78
CA - Canada 72
JP - Giappone 71
BD - Bangladesh 68
IQ - Iraq 53
MX - Messico 45
PK - Pakistan 45
EC - Ecuador 33
NL - Olanda 33
ID - Indonesia 32
CO - Colombia 30
AT - Austria 29
VE - Venezuela 29
JO - Giordania 23
PH - Filippine 23
UZ - Uzbekistan 23
ES - Italia 21
MA - Marocco 21
MU - Mauritius 21
PL - Polonia 21
TR - Turchia 19
BE - Belgio 18
PY - Paraguay 16
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 14
MY - Malesia 14
CL - Cile 13
KE - Kenya 13
TN - Tunisia 13
PE - Perù 12
EG - Egitto 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
BO - Bolivia 8
DZ - Algeria 8
NP - Nepal 8
AL - Albania 7
IR - Iran 7
JM - Giamaica 7
LT - Lituania 7
PT - Portogallo 7
UY - Uruguay 7
ET - Etiopia 6
IL - Israele 6
KW - Kuwait 6
SN - Senegal 6
EU - Europa 5
GE - Georgia 5
NI - Nicaragua 5
RS - Serbia 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
BH - Bahrain 3
BW - Botswana 3
BY - Bielorussia 3
GR - Grecia 3
KH - Cambogia 3
KR - Corea 3
LV - Lettonia 3
ML - Mali 3
PA - Panama 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 20.098
Città #
Dublin 1.113
Chandler 1.040
Jacksonville 856
Nanjing 718
San Jose 700
Hong Kong 695
Singapore 655
Ashburn 651
Dallas 554
Beijing 467
Boardman 385
Nanchang 301
Princeton 259
Lauterbourg 233
Lawrence 233
Wilmington 222
Hebei 219
Changsha 192
Shenyang 188
Los Angeles 176
Ho Chi Minh City 172
Jiaxing 152
Medford 148
Helsinki 124
Tianjin 122
Hanoi 118
New York 114
Shanghai 112
Moscow 104
Milan 98
Buffalo 91
Hangzhou 88
Woodbridge 82
Redondo Beach 80
San Genesio Ed Uniti 69
Ann Arbor 63
Tokyo 62
São Paulo 58
Johannesburg 57
Norwalk 47
Falls Church 46
Falkenstein 44
Verona 42
Munich 40
Seattle 39
Chicago 38
The Dalles 38
Brooklyn 36
Orem 35
Nuremberg 33
Houston 31
Pavia 29
Des Moines 27
San Francisco 27
Chennai 26
Council Bluffs 26
Santa Clara 26
Da Nang 25
Guangzhou 24
Montreal 24
Frankfurt am Main 23
Zhengzhou 23
Kunming 22
Toronto 22
Amman 21
Tashkent 21
Atlanta 19
Fairfield 19
Warsaw 19
Columbus 18
Rio de Janeiro 18
Stockholm 18
Baghdad 17
Brussels 17
Jinan 17
Mexico City 17
Thái Nguyên 17
Haiphong 16
Lahore 16
London 16
Washington 16
Curitiba 15
Dhaka 15
Guayaquil 15
Phoenix 15
Amsterdam 14
Boston 14
Denver 13
Naples 13
Palermo 13
Mumbai 12
Ningbo 12
Rome 12
Brasília 11
Buenos Aires 11
Nairobi 11
Tappahannock 11
Turku 11
Vienna 11
Belo Horizonte 10
Totale 13.105
Nome #
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 182
A method of gene transfer for the treatment of recessive CPVT 169
Tachicardia Ventricolare Polimorfa Catecolaminergica 163
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 162
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 158
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 143
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 142
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 131
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 128
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 128
[Computerized tomography study of 32 patients with disk hernia confirmed during surgical intervention]. 127
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 127
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 126
Gene-specific therapy for inherited arrhythmogenic diseases 125
Computer simulation of wild-type and mutant human cardiac Na+ current 124
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 123
Assessment of a personalized and distributed patient guidance system 123
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 122
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 122
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 121
Combining decision support system-generated recommendations with interactive guideline visualization for better informed decisions 120
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 119
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 116
Risk stratification in the Long-QT Syndrome 115
Patient-tailored Workflow Patterns from Clinical Practice Guidelines Recommendations. 115
Clinical timelines development from textual medical reports in Italian 115
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 113
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 112
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 112
A Recessive Variant of the Romano-Ward Long QT Syndrome 111
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 111
Information extraction from Italian medical reports: An ontology-driven approach 110
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 109
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. 109
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 109
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 109
Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome 108
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 108
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 107
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 106
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 105
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 105
Interplay between Clinical Guidelines and Organizational Workflow Systems. Experience from the MobiGuide project 105
Supporting shared decision making within the MobiGuide project. 104
A molecular basis for the therapy of the long QT syndrome 104
Cardiac Sodium Channel Diseases 103
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 103
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 103
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 101
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 101
The role of nurses in e-health: The MobiGuide project experience 101
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 100
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 99
Evaluation of BLS-D training in lay people. 98
R Engine Cell: integrating R into the i2b2 software infrastructure. 98
Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact 98
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 98
Genetics of ion-channel disorders 97
The long QT syndrome 97
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 96
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 96
Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling 96
Evaluation of spatial aspects of T-wave complexity in the Long QT syndrome 94
MobiGuide: a personalized and patient-centric decision-support system and its evaluation in the atrial fibrillation and gestational diabetes domains 94
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 93
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 92
Inherited arrhythmia: present and future perspectives for genetic therapy 92
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age 92
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 92
Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor (RyR2) 92
Cardiac ryanodine receptor calcium release deficiency syndrome 92
Genetic of Long QT, Brugada and Other Channelopathies 91
L-TYPE CALCIUM CHANNEL DISEASE 91
Brugada syndrome 91
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 90
Clinical and research data integration: the i2b2-FSM experience 90
Information Extraction from Italian medical reports: first steps towards clinical timelines development 90
Flecainide test in Brugada Syndrome: a reproducible but risky tool 90
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 90
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers 90
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 89
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias 88
Timothy Syndrome 87
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 87
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 87
Gender Differences in Patients with Brugada Syndrome and Arrhythmic Events: Data from a Survey on Arrhythmic Events in 678 Patients. 87
Experimental Therapy of genetic arrhythmias: disease-specific pharmacology. 86
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 86
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? 86
Inherited calcium channelopathies in the pathophysiology of arrhythmias. 86
Sodium current disorders: Geneticist's view 86
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 85
Genetics of Arrhythmogenic Disorders 84
Supervised methods to extract clinical events from cardiology reports in Italian 84
BRUGADA SYNDROME AND CONDUCTION SYSTEM DISEASE ARE LINKED TO A SINGLE SODIUM CHANNEL MUTATION. 83
Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. 83
Long QT Syndrome 83
RyRCa Leak Limits Cardiac Ca Windows Current Overcoming the Tonic Effect of Calmodulin Mice. 83
Catecholaminergic Polymorphic Ventricular Tachycardia 83
Patient-tailored workflow patterns from clinical practice guidelines recommendations 83
Totale 10.540
Categoria #
all - tutte 85.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021421 0 0 0 0 0 0 0 0 0 196 171 54
2021/20221.003 8 2 16 6 27 55 34 59 82 51 155 508
2022/20233.090 363 193 42 260 289 350 2 146 1.298 18 78 51
2023/20241.169 137 175 55 103 107 315 53 63 5 24 36 96
2024/20253.129 58 271 68 88 78 155 191 286 717 128 288 801
2025/20266.391 525 486 919 669 783 301 1.369 268 547 524 0 0
Totale 20.311